| | |
Per Share
|
| |
Total
|
| ||||||
首輪優先股發行價
|
| | | $ | 1,000 | | | | | $ | 2,425,000 | | |
B系列優先股發行價
|
| | | $ | 1,000 | | | | | $ | 2,425,000 | | |
Placement Agent’s fees(1)
|
| | | $ | 70 | | | | | $ | 339,500 | | |
扣除費用前的收益給我們
|
| | | $ | 930 | | | | | $ | 4,510,500 | | |
| | |
Page
|
| |||
關於本招股説明書補充資料
|
| | | | S-ii | | |
前瞻性陳述
|
| | | | S-iii | | |
SUMMARY | | | | | S-1 | | |
RISK FACTORS
|
| | | | S-4 | | |
USE OF PROCEEDS
|
| | | | S-10 | | |
DIVIDEND POLICY
|
| | | | S-10 | | |
我們提供的證券説明
|
| | | | S-11 | | |
PLAN OF DISTRIBUTION
|
| | | | S-16 | | |
LEGAL MATTERS
|
| | | | S-18 | | |
EXPERTS | | | | | S-18 | | |
在那裏您可以找到更多信息
|
| | | | S-18 | | |
通過引用而併入的信息
|
| | | | S-18 | | |
Prospectus
|
| ||||||
ABOUT THIS PROSPECTUS
|
| | | | 1 | | |
AGILE THERAPEUTICS, INC
|
| | | | 2 | | |
前瞻性陳述
|
| | | | 3 | | |
RISK FACTORS
|
| | | | 3 | | |
USE OF PROCEEDS
|
| | | | 3 | | |
股本説明
|
| | | | 4 | | |
DESCRIPTION OF WARRANTS
|
| | | | 7 | | |
債務證券説明
|
| | | | 9 | | |
DESCRIPTION OF RIGHTS
|
| | | | 16 | | |
DESCRIPTION OF UNITS
|
| | | | 17 | | |
PLAN OF DISTRIBUTION
|
| | | | 18 | | |
LEGAL MATTERS
|
| | | | 20 | | |
EXPERTS
|
| | | | 20 | | |
在那裏您可以找到更多信息
|
| | | | 20 | | |
通過引用而併入的信息
|
| | | | 20 | | |
| | |
Per Share
|
| |
Total
|
| ||||||
首輪優先股發行價
|
| | | $ | 1,000 | | | | | $ | 2,425,000 | | |
B系列優先股發行價
|
| | | $ | 1,000 | | | | | $ | 2,425,000 | | |
Placement Agent’s fees(1)
|
| | | $ | 70 | | | | | $ | 339,500 | | |
扣除費用前的收益給我們
|
| | | $ | 930 | | | | | $ | 4,510,500 | | |
|
ABOUT THIS PROSPECTUS
|
| | | | 1 | | |
|
AGILE THERAPEUTICS, INC
|
| | | | 2 | | |
|
前瞻性陳述
|
| | | | 3 | | |
|
RISK FACTORS
|
| | | | 3 | | |
|
USE OF PROCEEDS
|
| | | | 3 | | |
|
股本説明
|
| | | | 4 | | |
|
DESCRIPTION OF WARRANTS
|
| | | | 7 | | |
|
債務證券説明
|
| | | | 9 | | |
|
DESCRIPTION OF RIGHTS
|
| | | | 16 | | |
|
DESCRIPTION OF UNITS
|
| | | | 17 | | |
|
PLAN OF DISTRIBUTION
|
| | | | 18 | | |
|
LEGAL MATTERS
|
| | | | 20 | | |
|
EXPERTS
|
| | | | 20 | | |
|
在那裏您可以找到更多信息
|
| | | | 20 | | |
|
通過引用而併入的信息
|
| | | | 20 | | |